Literature DB >> 19436994

Superstitious conditioning as a model of delusion formation following chronic but not acute ketamine in humans.

Tom P Freeman1, Celia J A Morgan, Elissa Klaassen, Ravi K Das, Ana Stefanovic, Brigitta Brandner, H Valerie Curran.   

Abstract

BACKGROUND: Ketamine has previously been shown to induce delusion-like or referential beliefs, both acutely in healthy volunteers and naturalistically among nonintoxicated users of the drug. Delusions are theoretically underpinned by increased superstitious conditioning or the erroneous reinforcement of random events.
MATERIALS AND METHODS: Using a novel and objectively measured superstitious conditioning task, experiment 1 assessed healthy volunteers before and during placebo (n = 16), low-dose (n = 15), and high-dose ketamine (n = 16) under randomized and double-blind conditions. Experiment 2 used the same task to compare ketamine users (n = 18), polydrug controls (n = 19), and nondrug-using controls (n = 17).
RESULTS: In experiment 1, ketamine produced dose-dependent psychotomimetic effects but did not cause changes in superstitious conditioning. Experiment 2 found increased levels of superstitious conditioning among ketamine users compared to polydrug and nondrug-using controls, respectively, as evidenced by both objective task responses and subjective beliefs following the task.
CONCLUSIONS: Results indicate that chronic but not acute exposure to ketamine may increase the propensity to adopt superstitious conditioning. These findings are discussed in terms of acute and chronic ketamine models of delusion-like belief formation in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19436994     DOI: 10.1007/s00213-009-1564-x

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  43 in total

1.  Measurement of delusional ideation in the normal population: introducing the PDI (Peters et al. Delusions Inventory).

Authors:  E R Peters; S A Joseph; P A Garety
Journal:  Schizophr Bull       Date:  1999       Impact factor: 9.306

2.  Short scales for measuring schizotypy.

Authors:  Oliver Mason; Yvonne Linney; Gordon Claridge
Journal:  Schizophr Res       Date:  2005-10-15       Impact factor: 4.939

3.  Acute and chronic effects of ketamine on semantic priming: modeling schizophrenia?

Authors:  Ana Stefanovic; Brigitta Brandner; Elissa Klaassen; Roman Cregg; Mayavaty Nagaratnam; Lesley M Bromley; Ravi K Das; Susan L Rossell; Celia J A Morgan; H Valerie Curran
Journal:  J Clin Psychopharmacol       Date:  2009-04       Impact factor: 3.153

4.  The Spot-the-Word test: a robust estimate of verbal intelligence based on lexical decision.

Authors:  A Baddeley; H Emslie; I Nimmo-Smith
Journal:  Br J Clin Psychol       Date:  1993-02

5.  Beyond the K-hole: a 3-year longitudinal investigation of the cognitive and subjective effects of ketamine in recreational users who have substantially reduced their use of the drug.

Authors:  Celia J A Morgan; Lisa Monaghan; H Valerie Curran
Journal:  Addiction       Date:  2004-11       Impact factor: 6.526

6.  NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers.

Authors:  A K Malhotra; D A Pinals; H Weingartner; K Sirocco; C D Missar; D Pickar; A Breier
Journal:  Neuropsychopharmacology       Date:  1996-05       Impact factor: 7.853

7.  Non-contingent positive and negative reinforcement schedules of superstitious behaviors.

Authors:  C M Bloom; J Venard; M Harden; S Seetharaman
Journal:  Behav Processes       Date:  2007-02-13       Impact factor: 1.777

Review 8.  Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.

Authors:  Theresa H M Moore; Stanley Zammit; Anne Lingford-Hughes; Thomas R E Barnes; Peter B Jones; Margaret Burke; Glyn Lewis
Journal:  Lancet       Date:  2007-07-28       Impact factor: 79.321

9.  Psychological effects of ketamine in healthy volunteers. Phenomenological study.

Authors:  E Pomarol-Clotet; G D Honey; G K Murray; P R Corlett; A R Absalom; M Lee; P J McKenna; E T Bullmore; P C Fletcher
Journal:  Br J Psychiatry       Date:  2006-08       Impact factor: 9.319

10.  Substantia nigra/ventral tegmental reward prediction error disruption in psychosis.

Authors:  G K Murray; P R Corlett; L Clark; M Pessiglione; A D Blackwell; G Honey; P B Jones; E T Bullmore; T W Robbins; P C Fletcher
Journal:  Mol Psychiatry       Date:  2007-08-07       Impact factor: 15.992

View more
  10 in total

Review 1.  Toward a neurobiology of delusions.

Authors:  P R Corlett; J R Taylor; X-J Wang; P C Fletcher; J H Krystal
Journal:  Prog Neurobiol       Date:  2010-06-15       Impact factor: 11.685

Review 2.  Glutamatergic model psychoses: prediction error, learning, and inference.

Authors:  Philip R Corlett; Garry D Honey; John H Krystal; Paul C Fletcher
Journal:  Neuropsychopharmacology       Date:  2010-09-22       Impact factor: 7.853

Review 3.  Ketamine for chronic pain: risks and benefits.

Authors:  Marieke Niesters; Christian Martini; Albert Dahan
Journal:  Br J Clin Pharmacol       Date:  2014-02       Impact factor: 4.335

4.  Capgras syndrome induced by ketamine in a healthy subject.

Authors:  Philip R Corlett; Deepak C D'Souza; John H Krystal
Journal:  Biol Psychiatry       Date:  2010-04-10       Impact factor: 13.382

5.  Associative blocking to reward-predicting cues is attenuated in ketamine users but can be modulated by images associated with drug use.

Authors:  Tom P Freeman; Celia J A Morgan; Fiona Pepper; Oliver D Howes; James M Stone; H Valerie Curran
Journal:  Psychopharmacology (Berl)       Date:  2012-07-25       Impact factor: 4.530

6.  Selective augmentation of striatal functional connectivity following NMDA receptor antagonism: implications for psychosis.

Authors:  Orwa Dandash; Ben J Harrison; Ram Adapa; Raphael Gaillard; Francesco Giorlando; Stephen J Wood; Paul C Fletcher; Alex Fornito
Journal:  Neuropsychopharmacology       Date:  2014-08-21       Impact factor: 7.853

7.  Performance on a probabilistic inference task in healthy subjects receiving ketamine compared with patients with schizophrenia.

Authors:  Simon Evans; Basil Almahdi; Pervez Sultan; Imrat Sohanpal; Brigitta Brandner; Tracey Collier; Sukhi S Shergill; Roman Cregg; Bruno B Averbeck
Journal:  J Psychopharmacol       Date:  2012-03-02       Impact factor: 4.153

Review 8.  Ketamine plus Alcohol: What We Know and What We Can Expect about This.

Authors:  Natalia Harumi Correa Kobayashi; Sarah Viana Farias; Diandra Araújo Luz; Kissila Márvia Machado-Ferraro; Brenda Costa da Conceição; Cinthia Cristina Menezes da Silveira; Luanna Melo Pereira Fernandes; Sabrina de Carvalho Cartágenes; Vânia Maria Moraes Ferreira; Enéas Andrade Fontes-Júnior; Cristiane do Socorro Ferraz Maia
Journal:  Int J Mol Sci       Date:  2022-07-15       Impact factor: 6.208

9.  The epidemiology and patterns of acute and chronic toxicity associated with recreational ketamine use.

Authors:  Sarbjeet S Kalsi; David M Wood; Paul I Dargan
Journal:  Emerg Health Threats J       Date:  2011-04-15

Review 10.  The mechanisms of sudden-onset type adverse reactions to oseltamivir.

Authors:  R Hama; C L Bennett
Journal:  Acta Neurol Scand       Date:  2016-06-30       Impact factor: 3.209

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.